HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 50 filers reported holding HOOKIPA PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $342 | -57.3% | 555,636 | -38.9% | 0.00% | 0.0% |
| Q2 2023 | $801 | +8800.0% | 909,836 | +7610.5% | 0.00% | – |
| Q1 2023 | $9 | -70.0% | 11,800 | -68.0% | 0.00% | – |
| Q4 2022 | $30 | -100.0% | 36,900 | -74.1% | 0.00% | – |
| Q3 2022 | $191,000 | +24.0% | 142,200 | +50.2% | 0.00% | – |
| Q2 2022 | $154,000 | -83.2% | 94,700 | -75.9% | 0.00% | -100.0% |
| Q4 2021 | $915,000 | +215.5% | 392,800 | +1476.5% | 0.00% | – |
| Q2 2020 | $290,000 | – | 24,916 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
| Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
| Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
| HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
| DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
| Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
| ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
| HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
| Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |